S&P 500 Nears 6-Day Slide, Nasdaq 100 Faces Worst Week Since Late 2022: What’s Driving Markets Friday?
U.S. stocks are experiencing declines this Friday, on track of ending another week of negative performance.
Johnson & Johnson Children’s Cough Syrup Contaminated In Some Batches – WHO Poised to Issue Global Alert
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway.
FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel
German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
Novo Nordisk's acquisition of Cardior Pharmaceuticals clears regulatory hurdles, advancing cardiovascular treatment development with CDR132L. Learn about the promising phase 2 trials and strategic expansion. Deal expected to close Q2 2024.
Northrop Grumman And Elon Musk’s SpaceX Forge Alliance for US Spy Satellite Initiative
Northrop Grumman & SpaceX collaborate on a classified satellite initiative to enhance US surveillance capabilities. High-resolution imagery from low-Earth orbits diversifies intelligence methods, emphasizing distributed responsibility & sensor technology integration.
Stocks Edge Higher As Earnings Provide Support, Tesla Sinks To 15-Month Lows, Bitcoin Rebounds: What’s Driving Markets Thursday?
Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the latest wave of corporate earnings.
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth buying. Top 5 stocks with biggest gap between price and target: CCL, BIO, WBD, CZR, CCO.
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
Facing a shortage, GLP-1 weight loss drugs by Eli Lilly & Novo Nordisk struggle to meet demand. Learn about supply issues and efforts to address them, impacting availability till 2025.
Shell, Nigeria Ink Gas Deal To Fuel $3.8B Methanol Project: Report
Shell plc reportedly inked a deal with the Nigerian government to supply gas to the proposed $3.8 billion Brass methanol facility.
BP’s New Approach: Streamlines Structure For Efficiency And Clarity
BP (NYSE: BP) simplifying organizational structure, integrating regions & functions, while retaining financial reporting structure.